Helium-Based Plasma Radio Frequency Technology for Subdermal Coagulation in the Forehead: A Preliminary, Single-Center Retrospective Study.

Abstract

Background: Helium plasma radio frequency (RF) has emerged as a minimally invasive option for treating facial laxity. This study aims to evaluate its efficacy and safety for addressing forehead and brow laxity and ptosis.

Methods: In this retrospective, single-center study, medical records for 30 consecutive patients treated with helium plasma RF in the forehead and brow from March 2018 to September 2022 were reviewed. Inclusion criteria were age ≥18 years and having undergone treated in the forehead with helium plasma RF. Patients with prior or concurrent brow/forehead interventions were excluded. Primary endpoints were photographic assessments by blinded review and patient satisfaction measured via questionnaire.

Results: Of the 30 patients, seven patients consented to photographic review, and all 30 participated in the patient satisfaction questionnaire. Blinded reviewers correctly identified posttreatment images in 71.4% (5/7) of cases. Patient satisfaction was high, with 100% (30/30) reporting visible improvements and willingness to recommend the procedure. Notable improvements included reduced forehead lines (56.7%), elevated eyebrows (46.7%), and a more youthful appearance (46.7%). Adverse effects were minor and expected, with bruising recorded in 20% (6/30) of patients and edema/swelling in 16.7% (5/30) of patients, all resolving within 10 days, without intervention.

Conclusion: Helium plasma RF demonstrates significant potential as a minimally invasive treatment for brow and forehead laxity, with high patient satisfaction and a favorable safety profile. These preliminary findings warrant further prospective studies with larger sample sizes to confirm efficacy and long-term benefits. Helium plasma RF may provide a valuable alternative to traditional aesthetic procedures for the forehead and brow.

Level of evidence iv: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors   www.springer.com/00266 .